
Zyviva Labs was spun off from research at the University of California Davis. Zyviva operates an off-campus laboratory for the development of its technology.
Zyviva will supplant natural antioxidants and therapeutic compounds with high-performance synthetic products for the drug, supplement, nutraceutical, food, topical, cosmetic, and animal care markets. The optimized effectiveness, low cost of production, and high purity of Zyviva ingredients gives a competitive advantage over plant-based products. We estimate a total addressable market of $5 billion worldwide, predicted to grow to nearly $10 billion over the next ten years. We will curate exclusive Business-to-Business supply contracts with Fortune 500 companies to infuse their products with our ingredients.
At the same time, we will build value in the company by the development of new intellectual property and patents within the scope of our strategic plan.